OncoSynergy, Fighting Brain Cancer as the Family Business

OncoSynergy is a privately-held biotech company with a monoclonal antibody drug platform that is being developed for glioblastoma, the most aggressive form of brain cancer.

There is a great interview in Science Exchange this month with OncoSynergy's founder and CEO Shawn Carbonell, MD, PhD, and his wife, Anne-Marie Carbonell, MD, Vice President of Clinical Development.

In the interview, Shawn and Anne-Marie discuss their work on a drug that could be a game changer for patients with glioblastoma. They also talk about their involvement in the Race for Hope DC - the world's largest brain tumor community event, co-hosted by Accelerate Brain Cancer Cure and the National Brain Tumor Society.  OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.

Click HERE for the full article in Science Exchange.

Share |
February 27, 2014 04:35 PM
ABC2's Max Wallace leads the NCI's Director's Consumer Liaison Group that addresses research issues critical to improving outcomes for patients with all types of cancers.
February 26, 2014 12:00 AM
The coalition includes Accelerate Brain Cancer Cure, the Musella Foundation for Brain Tumor Research and Information, the National Brain Tumor Society and the Society for Neuro-Oncology.
February 20, 2014 03:29 PM
An in-depth update from Medscape on the debate surrounding the use of Avastin in treating GBM.  ABC2's petitioning of the FDA is noted.

Join us in our fight for a cure!

Twitter